Non-insulin-dependent Diabetes Mellitus Induced by Immune Checkpoint Inhibitor Therapy in an Insulinoma-associated Antigen-2 Autoantibody-positive Patient with Advanced Gastric Cancer

A 70-year-old man with insulinoma-associated antigen-2 autoantibodies developed diabetes mellitus (DM) without ketoacidosis after starting nivolumab to treat advanced gastric cancer. He subsequently exhibited preserved insulin-secretion capacity for over one year. Immune checkpoint inhibitors (ICIs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohara, Nobumasa, Kobayashi, Michi, Ikeda, Yohei, Hoshi, Takahiro, Morita, Shinichi, Kanefuji, Tsutomu, Yagi, Kazuyoshi, Suda, Takeshi, Takada, Toshinori, Hasegawa, Go, Sato, Yo, Hirano, Kenichiro, Kosugi, Shin-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056377/
https://www.ncbi.nlm.nih.gov/pubmed/31708539
http://dx.doi.org/10.2169/internalmedicine.3208-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056377/
https://www.ncbi.nlm.nih.gov/pubmed/31708539
http://dx.doi.org/10.2169/internalmedicine.3208-19

Ejemplares similares